Recruiting

iTEAR100

Sponsor:

Olympic Ophthalmics, Inc.

Code:

NCT05304637

Conditions

Dry Eye

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

iTEAR100 treatment

Study Details

Brief summary:

iTEAR generation 2 will be supplied t eligible subjects at Day 0. At Day 30, symptom questionnaires and ophthalmic exam will be performed.

Conditions

Dry Eye

Study ID

NCT05304637

Start date

Mar 1, 2022

Status verified date

Mar, 2022

Completion date

Jul 1, 2022

Anticipated

Primary completion date

Jun 1, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Dry eye

Exclusion Criteria:

  • unable to read consent
  • investigator discretion

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Therapy Arm

Patient receive iTEAR100 treatment

Interventions

iTEAR100 treatment

Vibratory energy to the external nasal nerve

Primary outcome measure

  • Schirmer score [ Time Frame: within 5 minutes of stimulation ]

Central Contacts and Locations

Central contacts

Michael Gertner, MD

650-283-9388mgertner@oo-med.com

Locations

Olympic Ophthalmics

Recruiting

Issaquah, Washington, United States, 98027

Contacts

Michael Gertner

650-283-9388mgertner@oo-med.com

Periman Eye Institute

Recruiting

Seattle, Washington, United States, 98119

More Information

Sponsor

Olympic Ophthalmics, Inc.

Last update posted

Mar 31, 2022

Last verified

Mar, 2022

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Olympic Ophthalmics, Inc. on 2022-03-31.